Temozolomide, which is a chemotherapeutic drug for treatment of glioblastoma, highly upregulates CHAC1, and overexpression of CHAC1 significantly influences temozolomide-mediated apoptosis in glioblastoma49. The gene discussed is CHAC1; the disease is glioblastoma.